Improving access to safe blood products through local production and technology transfer in blood establishments
(2015; 84 pages)


This report presents an overview of activities undertaken by the World Health Organization (WHO) to assess the need to support local production of quality recovered plasma by blood establishments in low- and middle-income countries (LMIC), so that it can be used as an active pharmaceutical ingredient (API) and improve access to safe blood products. The report identifies needs and analyses the challenges and opportunities faced by LMIC to improve production standards in their blood establishments. Relevant findings have been obtained through scientific publications, visits to selected regions and countries, questionnaire-driven criteria and a workshop where major stakeholders gathered and discussed the current status and ways to move forward. This action is in line with the objectives of World Health Assembly resolution WHA63.12, which supports access to quality, safe blood products at the global level.

El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019